Pentoxifylline-induced modulation of human leukocyte function in vitro

Area of Science:

• Immunology
• Pharmacology

Background:

• Pentoxifylline previously showed efficacy in protecting neonatal mice against Staphylococcus aureus infections.
• Previous studies indicated pentoxifylline stimulates leukocyte migration and accumulation in vivo.

Purpose of the Study:

• To investigate the effects of pentoxifylline on human leukocyte function in vitro.
• To determine the concentration-dependent immunomodulatory effects of pentoxifylline on leukocytes.

Main Methods:

• Assessing human leukocyte migration and microbicidal activity in vitro.
• Measuring leukocyte binding and uptake of Staphylococcus aureus.
• Quantifying phagocytic degranulation and leukocyte oxygen metabolism (H2O2 production, chemiluminescence).

Main Results:

• Low concentrations (0.01-0.1 mg/ml) of pentoxifylline stimulated leukocyte migration and microbicidal activity.
• Pentoxifylline at 0.001 mg/ml enhanced leukocyte oxygen metabolism, indicated by increased H2O2 and chemiluminescence.
• Higher concentrations (0.1-1 mg/ml) of pentoxifylline suppressed leukocyte functions in vitro.
• Low concentrations did not significantly affect Staphylococcus aureus binding or phagocytic degranulation.

Conclusions:

• Pentoxifylline's in vivo effects may directly involve leukocyte mobilization and microbicidal activity.
• Enhanced microbicidal activity by pentoxifylline could stem from increased leukocyte oxygen metabolism.
• Pentoxifylline acts as an in vitro immunomodulator, exhibiting both immunoenhancement and immunosuppression of leukocyte function.